Intercellular calcium signaling and gap junctional communication in astrocytes

被引:0
|
作者
Giaume, C [1 ]
Venance, L [1 ]
机构
[1] Coll France, INSERM, U114, F-75231 Paris 05, France
关键词
calcium waves; connexin; glial cells;
D O I
10.1002/(SICI)1098-1136(199809)24:1<50::AID-GLIA6>3.0.CO;2-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Two main characteristics of astrocytes are their elaborated intracellular calcium signaling and their high degree of intercellular communication mediated by gap junctional channels. In these cells a number of studies have contributed to demonstrate that the combination of these two properties provides a basis for a long-range signaling system within the brain. Intercellular calcium signaling, also termed calcium waves, allows astrocytes to communicate with each other and to interact with adjacent neurons. Most of the intra- and inter-cellular events involved in the initiation and propagation phases of this process has now been identified. This sequence of events includes the permeability of gap junction channels, which at the time-scale for calcium waves propagation, are likely permeated rather than closed by Ca2+ and/or related signaling molecules like IP3. In addition, in some studies an external component have been reported to participate to the propagation process. Finally, the control of the spread of intercellular calcium signaling has been demonstrated to occur at several levels including phospholipase C, IP3 receptors, intracellular Ca2+ stores, and cytoplasmic Ca2+ buffering. Accordingly, normal and pathological situations that affect one or several of these steps can be predicted to influence on astrocytic calcium waves. GLIA 24:50-64, 1998. (C) 1998 Wiiey-Liss, Inc.
引用
收藏
页码:50 / 64
页数:15
相关论文
共 50 条
  • [1] INTERCELLULAR CALCIUM SIGNALING BETWEEN ASTROCYTES AND OLIGODENDROCYTES VIA GAP JUNCTIONS IN CULTURE
    Parys, B.
    Cote, A.
    Gallo, V.
    De Koninck, P.
    Sik, A.
    NEUROSCIENCE, 2010, 167 (04) : 1032 - 1043
  • [2] Targeting gap junctional intercellular communication by hepatocarcinogenic compounds
    Leroy, Kaat
    Pieters, Alanah
    Tabernilla, Andres
    Cooreman, Axelle
    Van Campenhout, Raf
    Cogliati, Bruno
    Vinken, Mathieu
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2020, 23 (06): : 255 - 275
  • [3] Defective gap junctional intercellular communication in the carcinogenic process
    Mesnil, M
    Crespin, S
    Avanzo, JL
    Zaidan-Dagli, ML
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2005, 1719 (1-2): : 125 - 145
  • [4] Methamphetamine compromises gap junctional communication in astrocytes and neurons
    Castellano, Paul
    Nwagbo, Chisom
    Martinez, Luis R.
    Eugenin, Eliseo A.
    JOURNAL OF NEUROCHEMISTRY, 2016, 137 (04) : 561 - 575
  • [5] Modulation of intercellular calcium signaling in astrocytes by extracellular calcium and magnesium
    Stout, C
    Charles, A
    GLIA, 2003, 43 (03) : 265 - 273
  • [6] Effect of phenobarbital on hepatic gap junctional intercellular communication in rats
    Ito, S
    Tsuda, M
    Yoshitake, A
    Yanai, T
    Masegi, T
    TOXICOLOGIC PATHOLOGY, 1998, 26 (02) : 253 - 259
  • [7] The modulation of gap-junctional intercellular communication by lipid rafts
    Defamie, Norah
    Mesnil, Marc
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2012, 1818 (08): : 1866 - 1869
  • [8] Gap junctional intercellular communication as a target for liver toxicity and carcinogenicity
    Vinken, Mathieu
    Doktorova, Tatyana
    Decrock, Elke
    Leybaert, Luc
    Vanhaecke, Tamara
    Rogiers, Vera
    CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2009, 44 (04) : 201 - 222
  • [9] Activity-dependent neuronal control of gap-junctional communication in astrocytes
    Rouach, N
    Glowinski, J
    Giaume, C
    JOURNAL OF CELL BIOLOGY, 2000, 149 (07) : 1513 - 1526
  • [10] The psychostimulant modafinil enhances gap junctional communication in cortical astrocytes
    Liu, Xinhe
    Petit, Jean-Marie
    Ezan, Pascal
    Gyger, Joel
    Magistretti, Pierre
    Giaume, Christian
    NEUROPHARMACOLOGY, 2013, 75 : 533 - 538